The weak science behind psychedelics

“If vulnerable patients are going to take powerful hallucinogens, they deserve better evidence,” Olga Khazan writes in The Atlantic. Organizations researching psychedelics raised $millions – but the bubble is bursting: It’s been a bad year for fans of psychedelics.